These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34902620)

  • 1. Genetic determinants of virulence and antibiotic resistance are common for Pseudomonas aeruginosa ST235 isolates from cystic fibrosis patients from various geographical regions.
    Savinova T; Bocharova Y; Mayanskiy N; Chebotar I
    Diagn Microbiol Infect Dis; 2022 Mar; 102(3):115596. PubMed ID: 34902620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome features and antibiotic resistance of Pseudomonas aeruginosa strains isolated in patients with cystic fibrosis in the Russian Federation.
    Bocharova YA; Savinova TA; Lyamin AV; Kondratenko OV; Polikarpova SV; Zhilina SV; Fedorova NI; Semykin SY; Chaplin AV; Korostin DO; Mayansky NA; Chebotar IV
    Klin Lab Diagn; 2021 Oct; 66(10):629-634. PubMed ID: 34665950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of GES-19-producing Pseudomonas aeruginosa exoU+ belonging to the global high-risk clone ST235 in cystic fibrosis infection.
    Rosales-Reyes R; Esposito F; Fontana H; Lezana-Fernández JL; Lascurain R; De la Cruz MA; Fuga B; Lincopan N; Santos-Preciado JI
    Diagn Microbiol Infect Dis; 2021 Sep; 101(1):115454. PubMed ID: 34271235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The increasing threat of Pseudomonas aeruginosa high-risk clones.
    Oliver A; Mulet X; López-Causapé C; Juan C
    Drug Resist Updat; 2015; 21-22():41-59. PubMed ID: 26304792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-resistant Pseudomonas aeruginosa ST235 in cystic fibrosis.
    Lee AC; Jones AL
    Paediatr Respir Rev; 2018 Jun; 27():18-20. PubMed ID: 29914746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay among Resistance Profiles, High-Risk Clones, and Virulence in the Caenorhabditis elegans Pseudomonas aeruginosa Infection Model.
    Sánchez-Diener I; Zamorano L; López-Causapé C; Cabot G; Mulet X; Peña C; Del Campo R; Cantón R; Doménech-Sánchez A; Martínez-Martínez L; Arcos SC; Navas A; Oliver A
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population.
    Bradbury R; Champion A; Reid DW
    Respirology; 2008 Nov; 13(6):886-92. PubMed ID: 18811887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolved Aztreonam Resistance Is Multifactorial and Can Produce Hypervirulence in
    Jorth P; McLean K; Ratjen A; Secor PR; Bautista GE; Ravishankar S; Rezayat A; Garudathri J; Harrison JJ; Harwood RA; Penewit K; Waalkes A; Singh PK; Salipante SJ
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Draft genome sequence of an aminoglycoside-resistant RmtG-producing Pseudomonas aeruginosa ST235 isolated from a cystic fibrosis patient.
    Bueno MFC; Francisco GR; Cerdeira L; Ienne S; Souza TA; Lincopan N; de Oliveira Garcia D
    J Glob Antimicrob Resist; 2017 Mar; 8():106-107. PubMed ID: 28082143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenic characteristics of Pseudomonas aeruginosa bacteraemia isolates in a high-endemicity setting for ST175 and ST235 high-risk clones.
    Recio R; Sánchez-Diener I; Viedma E; Meléndez-Carmona MÁ; Villa J; Orellana MÁ; Mancheño M; Juan C; Zamorano L; Lora-Tamayo J; Chaves F; Oliver A
    Eur J Clin Microbiol Infect Dis; 2020 Apr; 39(4):671-678. PubMed ID: 31823150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudomonas aeruginosa epidemic high-risk clones and their association with horizontally-acquired β-lactamases: 2020 update.
    Del Barrio-Tofiño E; López-Causapé C; Oliver A
    Int J Antimicrob Agents; 2020 Dec; 56(6):106196. PubMed ID: 33045347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spread of extensively resistant VIM-2-positive ST235 Pseudomonas aeruginosa in Belarus, Kazakhstan, and Russia: a longitudinal epidemiological and clinical study.
    Edelstein MV; Skleenova EN; Shevchenko OV; D'souza JW; Tapalski DV; Azizov IS; Sukhorukova MV; Pavlukov RA; Kozlov RS; Toleman MA; Walsh TR
    Lancet Infect Dis; 2013 Oct; 13(10):867-76. PubMed ID: 23845533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial Resistance and Type III Secretion System Virulotypes of Pseudomonas aeruginosa Isolates from Dogs and Cats in Primary Veterinary Hospitals in Japan: Identification of the International High-Risk Clone Sequence Type 235.
    Hayashi W; Izumi K; Yoshida S; Takizawa S; Sakaguchi K; Iyori K; Minoshima KI; Takano S; Kitagawa M; Nagano Y; Nagano N
    Microbiol Spectr; 2021 Oct; 9(2):e0040821. PubMed ID: 34585944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypermutator Pseudomonas aeruginosa Exploits Multiple Genetic Pathways To Develop Multidrug Resistance during Long-Term Infections in the Airways of Cystic Fibrosis Patients.
    Colque CA; Albarracín Orio AG; Feliziani S; Marvig RL; Tobares AR; Johansen HK; Molin S; Smania AM
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32071060
    [No Abstract]   [Full Text] [Related]  

  • 15. Integron types, antimicrobial resistance genes, virulence gene profile, alginate production and biofilm formation in Iranian cystic fibrosis Pseudomonas aeruginosa isolates.
    Pournajaf A; Razavi S; Irajian G; Ardebili A; Erfani Y; Solgi S; Yaghoubi S; Rasaeian A; Yahyapour Y; Kafshgari R; Shoja S; Rajabnia R
    Infez Med; 2018 Sep; 26(3):226-236. PubMed ID: 30246765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study.
    López-Causapé C; de Dios-Caballero J; Cobo M; Escribano A; Asensio Ó; Oliver A; Del Campo R; Cantón R; Solé A; Cortell I; Asensio O; García G; Martínez MT; Cols M; Salcedo A; Vázquez C; Baranda F; Girón R; Quintana E; Delgado I; de Miguel MÁ; García M; Oliva C; Prados MC; Barrio MI; Pastor MD; Olveira C; de Gracia J; Álvarez A; Escribano A; Castillo S; Figuerola J; Togores B; Oliver A; López C; de Dios Caballero J; Tato M; Máiz L; Suárez L; Cantón R
    Int J Antimicrob Agents; 2017 Sep; 50(3):334-341. PubMed ID: 28735882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local outbreak of extended-spectrum β-lactamase SHV2a-producing Pseudomonas aeruginosa reveals the emergence of a new specific sub-lineage of the international ST235 high-risk clone.
    Royer G; Fourreau F; Boulanger B; Mercier-Darty M; Ducellier D; Cizeau F; Potron A; Podglajen I; Mongardon N; Decousser JW
    J Hosp Infect; 2020 Jan; 104(1):33-39. PubMed ID: 31369808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and multi drug resistance evolution of ST235 Pseudomonas aeruginosa strains in the intensive care unit of a Colombian hospital.
    Martinez E; Pérez JE; Buelvas F; Tovar C; Vanegas N; Stokes HW
    Res Microbiol; 2014 Dec; 165(10):852-6. PubMed ID: 25445011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the evolution of the mutational resistome of Pseudomonas aeruginosa in cystic fibrosis.
    López-Causapé C; Oliver A
    Future Microbiol; 2017 Dec; 12():1445-1448. PubMed ID: 29068237
    [No Abstract]   [Full Text] [Related]  

  • 20. Genome plasticity favours double chromosomal Tn4401b-bla
    Abril D; Marquez-Ortiz RA; Castro-Cardozo B; Moncayo-Ortiz JI; Olarte Escobar NM; Corredor Rozo ZL; Reyes N; Tovar C; Sánchez HF; Castellanos J; Guaca-González YM; Llanos-Uribe CE; Vanegas Gómez N; Escobar-Pérez J
    BMC Microbiol; 2019 Feb; 19(1):45. PubMed ID: 30786858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.